Hypoxia-Protective Azaphilone Adducts from Peyronellaea Glomerata

Tian-Xiao Li,Rui-Huan Liu,Xiao-Bing Wang,Jun Luo,Jian-Guang Luo,Ling-Yi Kong,Ming-Hua Yang
DOI: https://doi.org/10.1021/acs.jnatprod.7b00663
IF: 5.1
2018-01-01
Journal of Natural Products
Abstract:Peyronellones A and B (1 and 2), a pair of rare tetracyclic caged adducts of azaphilone with pyruvic acid, along with four new analogues (3-6), were isolated from solid cultures of the endophytic fungus Peyronellaea glomerata. Their structures were elucidated through spectroscopic analysis, and their absolute configurations were unambiguously determined by a combination of single-crystal X-ray crystallography, Rh-2(OCOCFCF3)(4)-induced ECD experiments, ECD calculations, and modified Mosher methods. Compound 2 (5 mu M) was found to have a significant hypoxia-protective effect that improved the survival rate of hypoxia/reoxygenation-treated human umbilical vein endothelial cells from 35% to 70%, which was equal to the potency of the positive control, verapamil. Flow cytometry analysis suggested 2 could inhibit H/R-induced late-stage apoptosis of this cell line.
What problem does this paper attempt to address?